Option Care Health (NASDAQ:OPCH) Issues FY 2025 Earnings Guidance

Option Care Health (NASDAQ:OPCH) issued an update on its FY 2025 earnings guidance on Monday morning. The company provided earnings per share guidance of 1.720-1.760 for the period, compared to the consensus earnings per share estimate of 1.640. The company issued revenue guidance of $5.6 billion-$5.7 billion, compared to the consensus revenue estimate of $5.6 billion. Option Care Health also updated its FY 2026 guidance to 1.820-1.920 EPS.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Option Care Health in a research note on Monday, December 29th. TD Cowen decreased their price objective on shares of Option Care Health from $30.00 to $27.00 and set a “hold” rating on the stock in a research report on Monday, November 3rd. Citigroup restated an “outperform” rating on shares of Option Care Health in a report on Tuesday. Bank of America upped their price target on shares of Option Care Health from $32.00 to $35.00 and gave the company a “buy” rating in a report on Tuesday, December 9th. Finally, Truist Financial set a $40.00 price objective on Option Care Health in a research report on Tuesday. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $37.17.

Option Care Health Stock Up 8.4%

Shares of NASDAQ OPCH opened at $34.75 on Wednesday. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.05 and a current ratio of 1.56. Option Care Health has a 1 year low of $24.24 and a 1 year high of $35.53. The stock’s 50-day simple moving average is $30.98 and its 200-day simple moving average is $29.42. The firm has a market cap of $5.52 billion, a price-to-earnings ratio of 27.58, a PEG ratio of 2.00 and a beta of 0.80.

Insider Activity

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 38,000 shares of the company’s stock in a transaction dated Monday, November 3rd. The shares were bought at an average price of $25.98 per share, with a total value of $987,240.00. Following the purchase, the director owned 413,390 shares of the company’s stock, valued at approximately $10,739,872.20. This represents a 10.12% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 0.64% of the company’s stock.

Option Care Health News Summary

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: Company-guided EPS above consensus for FY‑2025 and Q4 2025 (FY‑2025 EPS 1.720–1.760 vs. consensus 1.640; Q4 EPS 0.460–0.490 vs. consensus 0.440), which supports higher valuation expectations. Preliminary Results & Guidance
• Positive Sentiment: Morgan Stanley raised its price target to $38 and moved to an “overweight” rating, signaling buy-side momentum and implying further upside from current levels. Benzinga: Morgan Stanley Raise
• Positive Sentiment: Citizens JMP reaffirmed a “market outperform” rating and raised its target to $38 (from $36), echoing the bullish analyst view and providing independent validation of upside. TickerReport: Citizens JMP
• Neutral Sentiment: Management presented at the J.P. Morgan Healthcare Conference; the transcript is now available for investors seeking detail on strategy, margin drivers, and capital allocation. Insights could influence longer-term sentiment but are informational in the near term. JPM Conference Transcript
• Neutral Sentiment: Reported short‑interest figures appear inconsistent (zeros/NaN), so there’s no clear short‑squeeze signal from the published data — treat that data point cautiously.
• Negative Sentiment: FY‑2026 revenue guidance of $5.8–6.0B is below the consensus cited (~$6.1B), which could cap upside if investors focus on top‑line growth vs. EPS beats. Preliminary Results & Guidance

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. McIlrath & Eck LLC bought a new position in Option Care Health during the second quarter valued at about $37,000. Advisory Services Network LLC bought a new stake in shares of Option Care Health during the third quarter valued at approximately $35,000. Caitong International Asset Management Co. Ltd acquired a new position in shares of Option Care Health in the third quarter valued at $38,000. EverSource Wealth Advisors LLC raised its stake in shares of Option Care Health by 528.1% in the second quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock valued at $46,000 after purchasing an additional 1,183 shares in the last quarter. Finally, Quarry LP lifted its position in Option Care Health by 502.7% in the third quarter. Quarry LP now owns 1,549 shares of the company’s stock worth $43,000 after purchasing an additional 1,292 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.